Drugs Approved for Multiple Myeloma and Other Plasma Cell Neoplasms
This page lists cancer drugs approved by the Food and Drug Administration (FDA) for multiple myeloma and other plasma cell neoplasms. The list includes generic names, brand names, and common drug combinations, which are shown in capital letters. The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in multiple myeloma and other plasma cell neoplasms that are not listed here.
Drugs Approved for Multiple Myeloma and Other Plasma Cell Neoplasms
- Abecma (Idecabtagene Vicleucel)
- Alkeran for Injection (Melphalan Hydrochloride)
- Alkeran Tablets (Melphalan)
- Aredia (Pamidronate Disodium)
- Belantamab Mafodotin-blmf
- BiCNU (Carmustine)
- Blenrep (Belantamab Mafodotin-blmf)
- Bortezomib
- Carfilzomib
- Carmustine
- Carvykti (Ciltacabtagene Autoleucel)
- Ciltacabtagene Autoleucel
- Cyclophosphamide
- Daratumumab
- Daratumumab and Hyaluronidase-fihj
- Darzalex (Daratumumab)
- Darzalex Faspro (Daratumumab and Hyaluronidase-fihj)
- Doxil (Doxorubicin Hydrochloride Liposome)
- Doxorubicin Hydrochloride Liposome
- Elotuzumab
- Empliciti (Elotuzumab)
- Evomela (Melphalan Hydrochloride)
- Idecabtagene Vicleucel
- Isatuximab-irfc
- Ixazomib Citrate
- Kyprolis (Carfilzomib)
- Lenalidomide
- Melphalan
- Melphalan Hydrochloride
- Mozobil (Plerixafor)
- Ninlaro (Ixazomib Citrate)
- Pamidronate Disodium
- Plerixafor
- Pomalidomide
- Pomalyst (Pomalidomide)
- Revlimid (Lenalidomide)
- Sarclisa (Isatuximab-irfc)
- Selinexor
- Thalidomide
- Thalomid (Thalidomide)
- Velcade (Bortezomib)
- Xpovio (Selinexor)
- Zoledronic Acid
- Zometa (Zoledronic Acid)